A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

• Status: Unknown status
• Trial end date: 2012-12-01

Summary

Comparison between the effectiveness of one anti-diabetic drug (Metformin, To combination of this drug and additional drug (Janufer), In the community setting.

• Phase: Phase 3

Details

• Lead Sponsor: Meir Medical Center
• Collaborator: Clalit Health Services
• Treatments: Metformin